NEW YORK (VINnews) — Neuralink founder Elon Musk announced Monday that the first human being had received an implant from the brain-chip startup on Sunday and is recovering well, according to a Guardian report.
Join our WhatsApp groupSubscribe to our Daily Roundup Email
The US Food and Drug Administration (FDA) had given the company clearance last year to conduct its first trial to test its implant on humans.
In a post on X, formerly Twitter, Musk said that “promising” brain activity had been detected after the procedure and the patient was “recovering well”.
The company’s goal is to connect human brains to computers to help tackle complex neurological conditions.
“Initial results show promising neuron spike detection,” Musk added.
Spikes are activity by neurons, which the National Institute of Health describes as cells that use electrical and chemical signals to send information around the brain and to the body.
The startup’s Prime study is a trial for its wireless brain-computer interface to evaluate the safety of the implant and surgical robot.
The study will assess the functionality of the interface, which enables people with quadriplegia, or paralysis of all four limbs, to control devices with their thoughts, according to the company’s website.
Several rival companies have already implanted similar devices.
This includes the École Polytechnique Fédérale in Lausanne (EPFL), in Switzerland, which has successfully enabled a paralysed man to walk just by thinking.
That was achieved by putting electronic implants on his brain and spine which wirelessly communicate thoughts to his legs and feet.
Neuralink received FDA clearance last year for its first trial to test the company’s implant in humans, a critical milestone for the startup. Reuters reported in June that the company was valued as high as $5bn, based on private stock trades.
Neuralink announced the implant trial in September. The company said that during the study, a robot developed by the company will surgically place the implants’ “ultra-fine” threads that help transmit signals in participants’ brains.